Endocrine responses and food intake in fasted individuals under the influence of glucose ingestion.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
11
2018
accepted:
15
01
2019
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
28
10
2019
Statut:
epublish
Résumé
Different metabolic conditions can affect what and how much we eat. Hormones of glucose metabolism and adipokines such as adiponectin take part in the control of these decisions and energy balance of the body. However, a comprehensive understanding of how these endocrine and metabolic factors influence food intake has not been reached. We hypothesised that the amount of food a person consumes differs substantially after a fasting period even after the energy deficit was partially removed by glucose ingestion and endocrine signals like insulin and C-peptide indicated a high glucose metabolic status. Furthermore, the macronutrient composition of the consumed food and a possible association with adiponectin under the influence of glucose ingestion was assessed. In a within-subject design, 24 healthy males participated in both a fasting (42 h) and control (non-fasting) condition. A total of 20 blood samples from each subject were collected during each condition to assess serum levels of adiponectin, insulin, C-peptide, cortisol and ACTH. At the end of each condition food intake was measured with an ad libitum buffet after the acute energy deficit was compensated using a carbohydrate-rich drink. The total amount of caloric intake and single macronutrients was higher after the fasting intervention after replenishment with glucose. All recorded hormone levels, except for adiponectin, were significantly different for at least one of the study intervals. The relative proportions of the macronutrient composition of the consumed food were stable in both conditions under the influence of glucose ingestion. In the non-fasting condition, the relative amount of protein intake correlated with adiponectin levels during the experiment. An anabolic glucose metabolism after glucose ingestion following a fasting intervention did not even out energy ingestion compared to a control group with regular food intake and glucose ingestion. Anorexigenic hormones like insulin in this context were not able despite higher levels than in the control condition to ameliorate the drive for food intake to normal or near normal levels. Relative macronutrient intake remains stable under these varying metabolic conditions and glucose influence. Serum adiponectin levels showed a positive association with the relative protein intake in the non-fasting condition under the influence of glucose although adiponectin levels overall did not differ in between the conditions.
Identifiants
pubmed: 30682147
doi: 10.1371/journal.pone.0211514
pii: PONE-D-18-31981
pmc: PMC6347228
doi:
Substances chimiques
Adiponectin
0
Blood Glucose
0
Insulin
0
Adrenocorticotropic Hormone
9002-60-2
Glucose
IY9XDZ35W2
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0211514Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
FEBS Lett. 2008 Jan 9;582(1):74-80
pubmed: 18054335
Proc Nutr Soc. 2012 Aug;71(3):379-89
pubmed: 22475574
Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E436-43
pubmed: 23269410
Int J Obes (Lond). 2016 Nov;40(11):1662-1670
pubmed: 27339607
Nat Rev Neurosci. 2014 Jun;15(6):367-78
pubmed: 24840801
J Clin Endocrinol Metab. 2007 Nov;92(11):4480-4
pubmed: 17785367
J Nutr. 2016 Mar;146(3):637-45
pubmed: 26791555
Clin Endocrinol (Oxf). 2004 Sep;61(3):332-8
pubmed: 15355449
Gastroenterology. 2017 May;152(7):1718-1727.e3
pubmed: 28193517
Cancer Causes Control. 2017 Mar;28(3):247-258
pubmed: 28210884
J Nutr Biochem. 2012 Aug;23(8):867-74
pubmed: 21852089
Appl Physiol Nutr Metab. 2007 Jun;32(3):505-11
pubmed: 17510690
JAMA. 2012 Jun 27;307(24):2627-34
pubmed: 22735432
Obesity (Silver Spring). 2011 Nov;19(11):2198-204
pubmed: 21455123
Physiol Res. 2006;55(3):277-83
pubmed: 16083306
Clin Chem Lab Med. 2006;44(10):1264-8
pubmed: 17032140
Br J Nutr. 2000 Mar;83 Suppl 1:S33-8
pubmed: 10889790
J Nutr Biochem. 2009 Nov;20(11):831-9
pubmed: 19716279
J Hum Nutr Diet. 2015 Feb;28 Suppl 2:16-23
pubmed: 24251378
Cell Metab. 2006 Feb;3(2):141-6
pubmed: 16459315
Brain Res Bull. 1993;32(5):543-8
pubmed: 8221150
Diabetes. 2010 Apr;59(4):1101-7
pubmed: 20068139
Prog Neurobiol. 2014 Mar;114:84-101
pubmed: 24394671
Eur J Nutr. 2016 Nov;55(Suppl 2):17-23
pubmed: 27882410
J Clin Endocrinol Metab. 2006 Apr;91(4):1477-83
pubmed: 16434457
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14217-22
pubmed: 14617771
Cell. 2015 Mar 26;161(1):119-132
pubmed: 25815990
Nat Rev Dis Primers. 2017 Jun 15;3:17034
pubmed: 28617414
Int J Pediatr Endocrinol. 2009;2009:141753
pubmed: 19946401
Cell Metab. 2007 Jul;6(1):55-68
pubmed: 17618856
Am J Clin Nutr. 2000 Apr;71(4):901-7
pubmed: 10731495
Ann Nutr Metab. 2013;63(1-2):159-67
pubmed: 24021709
Am J Clin Nutr. 2005 Mar;81(3):570-7
pubmed: 15755824
Science. 2007 Sep 7;317(5843):1355
pubmed: 17690262
Clin Endocrinol (Oxf). 2004 Apr;60(4):429-33
pubmed: 15049956
Metab Syndr Relat Disord. 2008 Jun;6(2):87-102
pubmed: 18510434
Eur J Nutr. 2016 Nov;55(Suppl 2):25-43
pubmed: 27900447
Nutr Rev. 2010 Apr;68(4):214-31
pubmed: 20416018
Exp Physiol. 2006 Jul;91(4):693-703
pubmed: 16627573
Obes Surg. 2006 Nov;16(11):1425-32
pubmed: 17132406
Int J Obes (Lond). 2016 Feb;40(2):305-11
pubmed: 26278005
Int J Obes (Lond). 2005 Aug;29(8):998-1001
pubmed: 15917861